Biblio

Soundararajan R, Wang G, Petkova A, Uchegbu IF, Schätzlein AG.  2020.  Hyaluronidase Coated Molecular Envelope Technology Nanoparticles Enhance Drug Absorption via the Subcutaneous Route.. Mol Pharm. 17(7):2599-2611.

Pérez-Cantero A, Serrano DR, Navarro-Rodríguez P, Schätzlein AG, Uchegbu IF, Torrado JJ, Capilla J.  2019.  Increased Efficacy of Oral Fixed-Dose Combination of Amphotericin B and AHCC Natural Adjuvant against Aspergillosis.. Pharmaceutics. 11(9)

Wang Z, Xiong G, Tsang WChun, Schätzlein AG, Uchegbu IF.  2019.  Nose-to-Brain Delivery.. J Pharmacol Exp Ther. 370(3):593-601.

Odunze U, O'Brien F, Godfrey L, Schatzlein A, Uchegbu I.  2019.  Unusual Enthalpy Driven Self Assembly at Room Temperature with Chitosan Amphiphiles.. Pharm Nanotechnol. 7(1):57-71.

Godfrey L, Iannitelli A, Garrett NLaura, Moger J, Imbert I, King T, Porreca F, Soundararajan R, Lalatsa A, Schätzlein AG et al..  2017.  Nanoparticulate peptide delivery exclusively to the brain produces tolerance free, analgesia.. Journal of Controlled Release. E-pub ahead of print

Soundararajan R, Sasaki K, Godfrey L, Odunze U, Fereira N, Schatzlein A, Uchegbu I.  2016.  Direct in vivo evidence on the mechanism by which nanoparticles facilitate the absorption of a water insoluble, P-gp substrate.. International Journal of Pharmaceutics. 514(1):121-132.

Fisusi FA, Siew A, Chooi KWai, Okubanjo O, Garrett N, Lalatsa K, Serrano D, Summers I, Moger J, Stapleton P et al..  2016.  Lomustine Nanoparticles Enable Both Bone Marrow Sparing and High Brain Drug Levels - A Strategy for Brain Cancer Treatments.. Pharmaceutical Research. :1-15.

Lalatsa A, Schätzlein AG, Garrett NL, Moger J, Briggs M, Godfrey L, Iannitelli A, Freeman J, Uchegbu IF.  2015.  Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration.. Journal of controlled release : official journal of the Controlled Release Society. 197:87-96.

Serrano DR, Lalatsa A, M Dea-Ayuela A, Bilbao-Ramos PE, Garrett NL, Moger J, Guarro J, Capilla J, M Ballesteros P, Schätzlein AG et al..  2015.  Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles.. Molecular pharmaceutics. 12(2):420-431.

Uchegbu IF, Carlos M, McKay C, Hou X, Schätzlein AG.  2014.  Chitosan amphiphiles provide new drug delivery opportunities. Polymer International.

Uchegbu IF, Jones MC, Corrente F.  2014.  The Oral and Intranasal Delivery of Propofol Using Chitosan Amphiphile Nanoparticles. Pharmaceutical ….

Chooi KW, Carlos MIsabel Sim, Soundararajan R, Gaisford S, Arifin N, Schätzlein AG, Uchegbu IF.  2014.  Physical Characterisation and Long‐Term Stability Studies on Quaternary Ammonium Palmitoyl Glycol Chitosan (GCPQ)—A New Drug Delivery Polymer. Journal of Pharmaceutical Sciences.

Lalatsa A, Schätzlein AG, Uchegbu IF.  2014.  Strategies To Deliver Peptide Drugs to the Brain. Molecular pharmaceutics. 11(4):1081-1093.

Mazza M, Notman R, Anwar J, Rodger A, Hicks M, Parkinson G, McCarthy D, Daviter T, Moger J, Garrett N et al..  2013.  Nanofiber-based delivery of therapeutic peptides to the brain. ACS nano. 7(2):1016-1026.

Le HThi Bich, Schätzlein AG, Uchegbu IF.  2013.  Polymer Hydrophobicity Has a Positive Effect on the Oral Absorption of Cyclosporine A from Poly(ethylenimine) Based Nanomedicines. Pharmaceutical Nanotechnology. 1:15-25.

Lalatsa A, Garrett NL, Ferrarelli T, Moger J, Schätzlein AG, Uchegbu IF.  2012.  Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles.. Molecular pharmaceutics. 9(6):1764-1774.

Siew A, Le H, Thiovolet M, Gellert P, Schatzlein A, Uchegbu I.  2012.  Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles.. Molecular pharmaceutics. 9(1):14-28.

Garrett NLaura, Lalatsa A, Uchegbu I, Schatzlein A, Moger J.  2012.  Exploring uptake mechanisms of oral nanomedicines using multimodal nonlinear optical microscopy. Journal of Biophotonics. 5(5-6):458-468.

Garrett NL, Lalatsa A, Begley D, Mihoreanu L., Uchegbu IF, Schätzlein AG, Moger J.  2012.  Label‐free imaging of polymeric nanomedicines using coherent anti‐stokes Raman scattering microscopy. Journal of Raman Spectroscopy. 43(5):681-688.

Lalatsa A, Lee V, Malkinson JP, Zloh M, Schätzlein AG, Uchegbu IF.  2012.  A Prodrug Nanoparticle Approach for the Oral Delivery of a Hydrophilic Peptide, Leucine 5-enkephalin, to the Brain. Molecular pharmaceutics. 9(6):1665-1680.

Ahmad S, Johnston BF, Mackay SP, Schätzlein AG, Gellert P, Sengupta D, Uchegbu IF.  2010.  In silico modelling of drug-polymer interactions for pharmaceutical formulations.. Journal of The Royal Society Interface. 7 Suppl 4:S423-33.

Qu X, Khutoryanskiy VV, Stewart A, Rahman S, Papahadjopoulos-Sternberg B, Dufes C, McCarthy D, Wilson CG, Lyons R, Carter KC et al..  2006.  Carbohydrate-based micelle clusters which enhance hydrophobic drug bioavailability by up to 1 order of magnitude.. Biomacromolecules. 7(12):3452-3459.

Uchegbu IF, Sadiq L, Arastoo M, Gray AI, Wang W, Waigh RD, Schätzlein AG.  2001.  Quaternary ammonium palmitoyl glycol chitosan--a new polysoap for drug delivery.. International Journal of Pharmaceutics. 224(1-2):185-199.